Abstract:Since their identification over twenty-five years ago, the plethora of cell-penetrating peptides (CPP) and their applications has skyrocketed. These 5 to 30 amino acid in length peptides have the unique property of breaching the cell membrane barrier while carrying cargoes larger than themselves into cells in an intact, functional form. CPPs can be conjugated to fluorophores, activatable probes, radioisotopes or contrast agents for imaging tissues, such as tumors. There is no singular mechanism for translocation of CPPs into a cell, and therefore, many CPPs are taken up by a multitude of cell types, creating the challenge of tumor-specific translocation and hindering clinical effectiveness. Varying strategies have been developed to combat this issue and enhance their diagnostic potential by derivatizing CPPs for better targeting by constructing specific cell-activated forms. These methods are currently being used to image integrin-expressing tumors, breast cancer cells, human histiocytic lymphoma and protease-secreting fibrosarcoma cells, to name a few. Additionally, identifying safe, effective therapeutics for malignant tumors has long been an active area of research. CPPs can circumvent many of the complications found in treating cancer with conventional therapeutics by targeted delivery of drugs into tumors, thereby decreasing off-target side effects, a feat not achievable by currently employed conventional chemotherapeutics. Myriad types of chemotherapeutics such as tyrosine kinase inhibitors, antitumor antibodies and nanoparticles can be functionally attached to these peptides, leading to the possibility of delivering established and novel cancer therapeutics directly to tumor tissue. While much research is needed to overcome potential issues with these peptides, they offer a significant advancement over current mechanisms to treat cancer. In this review, we present a brief overview of the research, leading to identification of CPPs with a comprehensive state-of-the-art review on the role of these novel peptides in both cancer diagnostics as well as therapeutics.

Progress in tumour-targeted drug delivery based on cell-penetrating peptides

Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.

Penetrating peptides: Applications in drug delivery

The role of cell‐penetrating peptides in potential anti‐cancer therapy

The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides As Drug Delivery Systems Based on Tumor Microenvironment

Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging

Cell penetrating peptides: Highlighting points in cancer therapy

Application of activatable cell-penetrating peptide in the field of tumor therapy

Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics

Recent Progress of Cell-Penetrating Peptides As New Carriers for Intracellular Cargo Delivery.

[Advances in the research and application of cell penetrating peptides]

Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision delivery

Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides

Cell Penetrating Peptides in the Delivery of Biopharmaceuticals

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

Advancement and application of novel cell-penetrating peptide in cancer management

Cell‐penetrating Peptides for Cancer Treatment: Current State and Future Directions

Progress in delivery of exogenous molecules mediated by cell-penetrating peptides into cells

Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer

Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers